Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Communications Medicine
|
October 30, 2024
Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria
Luis Antonio Díaz, Jeffrey V Lazarus, Eduardo Fuentes-López, et al.
Hepatology Communications
|
October 24, 2024
Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis
Alvi Husni Islam, Luis Antonio Díaz, Francisco Idalsoaga, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 20, 2020
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study
Donghee Kim, Nia Adeniji, Nyann Latt, et al.
Journal of Hepatology
|
November 22, 2023
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes
Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, et al.
The American Journal of Gastroenterology
|
March 27, 2025
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease
Naim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, et al.
Alimentary Pharmacology & Therapeutics
|
April 22, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes
Suzanne Sharpton, Luis Antonio Díaz, Kay Pepin, et al.
Egastroenterology
|
April 25, 2025
Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study
Francisco Idalsoaga, Luis Antonio Diaz, Winston Dunn, et al.
Alimentary Pharmacology & Therapeutics
|
February 19, 2025
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort Study
Francisco Idalsoaga, Luis Antonio Díaz, Leonardo Guizzetti, et al.
Hepatology (Baltimore, Md.)
|
May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global study
Vania Cari, María Ignacia Perez, Ignacio Tellez, et al.
Hepatology Communications
|
March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter study
Francisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Communications Medicine
|
October 30, 2024
Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria
Luis Antonio Díaz, Jeffrey V Lazarus, Eduardo Fuentes-López, et al.
Hepatology Communications
|
October 24, 2024
Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis
Alvi Husni Islam, Luis Antonio Díaz, Francisco Idalsoaga, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 20, 2020
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study
Donghee Kim, Nia Adeniji, Nyann Latt, et al.
Journal of Hepatology
|
November 22, 2023
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes
Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, et al.
The American Journal of Gastroenterology
|
March 27, 2025
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease
Naim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, et al.
Alimentary Pharmacology & Therapeutics
|
April 22, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes
Suzanne Sharpton, Luis Antonio Díaz, Kay Pepin, et al.
Egastroenterology
|
April 25, 2025
Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study
Francisco Idalsoaga, Luis Antonio Diaz, Winston Dunn, et al.
Alimentary Pharmacology & Therapeutics
|
February 19, 2025
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort Study
Francisco Idalsoaga, Luis Antonio Díaz, Leonardo Guizzetti, et al.
Hepatology (Baltimore, Md.)
|
May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global study
Vania Cari, María Ignacia Perez, Ignacio Tellez, et al.
Hepatology Communications
|
March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter study
Francisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.
Page
of 7